Compare FOUR & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FOUR | WGS |
|---|---|---|
| Founded | 1999 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 2.7B |
| IPO Year | 2020 | 2020 |
| Metric | FOUR | WGS |
|---|---|---|
| Price | $39.16 | $63.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 25 | 8 |
| Target Price | $52.86 | ★ $93.50 |
| AVG Volume (30 Days) | ★ 1.7M | 736.8K |
| Earning Date | 11-05-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 62.37 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,180,000,000.00 | $427,539,000.00 |
| Revenue This Year | $22.40 | $12.70 |
| Revenue Next Year | $13.37 | $24.31 |
| P/E Ratio | $27.53 | ★ N/A |
| Revenue Growth | 25.50 | ★ 39.97 |
| 52 Week Low | $34.56 | $32.21 |
| 52 Week High | $77.50 | $170.87 |
| Indicator | FOUR | WGS |
|---|---|---|
| Relative Strength Index (RSI) | 45.88 | 34.60 |
| Support Level | $34.92 | $56.36 |
| Resistance Level | $51.46 | $63.31 |
| Average True Range (ATR) | 1.63 | 5.42 |
| MACD | 0.40 | -1.04 |
| Stochastic Oscillator | 65.23 | 3.96 |
Shift4 Payments Inc is an independent provider of software and payment processing solutions in the U.S., expanding internationally. Its payments platform offers integrated products and services across in-store, online, mobile and tablet-based channels, including end-to-end payment processing, merchant acquiring services, a proprietary omni-channel gateway, eCommerce capabilities, and reporting tools. The company distributes its services through internal sales teams and partners, including independent software vendors (ISVs) and value-added resellers (VARs). Revenue is predominantly recurring, derived mainly from processing fees and subscription revenue from POS software, business intelligence tools and other technology solutions. The company derives maximum revenue from the United States.
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.